Beaumont Financial Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-14,163
Closed -$1.41M 304
2019
Q3
$1.41M Sell
14,163
-380
-3% -$36.1K 0.14% 105
2019
Q2
$1.34M Sell
14,543
-48
-0.3% -$4.56K 0.14% 103
2019
Q1
$1.38M Buy
14,591
+30
+0.2% +$2.62K 0.15% 96
2018
Q4
$933K Sell
14,561
-970
-6% -$71.6K 0.15% 86
2018
Q3
$1.39M Hold
15,531
0.14% 84
2018
Q2
$1.23M Sell
15,531
-34
-0.2% -$2.82K 0.13% 86
2018
Q1
$1.39M Buy
15,565
+4,234
+37% +$406K 0.15% 87
2017
Q4
$1.18M Sell
11,331
-694
-6% -$78.3K 0.14% 94
2017
Q3
$1.75M Buy
12,025
+162
+1% +$22.1K 0.22% 83
2017
Q2
$1.54M Sell
11,863
-667
-5% -$81.7K 0.2% 84
2017
Q1
$1.56M Buy
12,530
+840
+7% +$101K 0.21% 84
2016
Q4
$1.35M Buy
11,690
+94
+0.8% +$10.5K 0.2% 82
2016
Q3
$1.21M Hold
11,596
0.19% 87
2016
Q2
$1.14M Sell
11,596
-396
-3% -$41K 0.19% 82
2016
Q1
$1.38M Buy
11,992
+396
+3% +$40.8K 0.22% 77
2015
Q4
$1.39M Hold
11,596
0.23% 68
2015
Q3
$1.34M Hold
11,596
0.19% 79
2015
Q2
$1.34M Sell
11,596
-396
-3% -$45.3K 0.19% 79
2015
Q1
$1.38M Hold
11,992
0.05% 93
2014
Q4
$1.34M Hold
11,992
0.06% 93
2014
Q3
$1.14M Hold
11,992
0.07% 98
2014
Q2
$1.03M Sell
11,992
-110
-0.9% -$8.37K 0.07% 105
2014
Q1
$845K Sell
12,102
-502
-4% -$39.8K 0.07% 92
2013
Q4
$1.06M Buy
12,604
+1,122
+10% +$88.8K 0.09% 91
2013
Q3
$885K Sell
11,482
-28
-0.2% -$1.96K 0.08% 92
2013
Q2
$673K Buy
+11,510
New +$693K 0.06% 102

Other funds holding CELG

Beaumont Financial Advisors's CELG Position: Q4 2019 in Review

Beaumont Financial Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 14,163 shares — an estimated $1.41M sold.

Beaumont Financial Advisors first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.75M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Beaumont Financial Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Beaumont Financial Advisors sold 14,163 Celgene Corp shares in Q4 2019, an estimated $1.41M.
  • Beaumont Financial Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Beaumont Financial Advisors's Celgene Corp position peaked at $1.75M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Beaumont Financial Advisors's 13F filing for Q4 2019, filed 6 Feb 2020.